Ellen Ambegia

1.1k total citations
7 papers, 925 citations indexed

About

Ellen Ambegia is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Ellen Ambegia has authored 7 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Immunology. Recurrent topics in Ellen Ambegia's work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (4 papers) and RNA modifications and cancer (2 papers). Ellen Ambegia is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (4 papers) and RNA modifications and cancer (2 papers). Ellen Ambegia collaborates with scholars based in Canada and United States. Ellen Ambegia's co-authors include Ian MacLachlan, Lorne Palmer, Adam D. Judge, Marjorie Robbins, Kevin McClintock, Lloyd B. Jeffs, Shannon Ewanick, Lina Hu, Iran Tavakoli and Jasna Levi and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

Ellen Ambegia

7 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ellen Ambegia Canada	6	837	180	155	144	132	7	925
Liu Liang Qin China	5	772 0.9×	154 0.9×	111 0.7×	102 0.7×	106 0.8×	6	893
Timothy Racie United States	3	844 1.0×	164 0.9×	123 0.8×	105 0.7×	110 0.8×	5	987
Richard I. Hogrefe United States	16	1.1k 1.3×	136 0.8×	157 1.0×	81 0.6×	79 0.6×	27	1.2k
Luke H. Rhym United States	11	719 0.9×	111 0.6×	155 1.0×	65 0.5×	66 0.5×	12	802
Keith Bowman United States	10	1.2k 1.4×	363 2.0×	200 1.3×	173 1.2×	70 0.5×	16	1.4k
Nuphar Veiga Israel	9	851 1.0×	71 0.4×	202 1.3×	163 1.1×	144 1.1×	10	1.0k
Darren H. Wakefield United States	9	842 1.0×	218 1.2×	145 0.9×	78 0.5×	88 0.7×	10	997
Günther Hasenpusch Germany	11	918 1.1×	64 0.4×	331 2.1×	113 0.8×	89 0.7×	14	1.1k
Michaela Jeong South Korea	8	656 0.8×	64 0.4×	115 0.7×	121 0.8×	88 0.7×	11	816
Niels Dammes Israel	9	859 1.0×	88 0.5×	178 1.1×	186 1.3×	92 0.7×	10	1.1k

Countries citing papers authored by Ellen Ambegia

Since Specialization

Citations

This map shows the geographic impact of Ellen Ambegia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Ambegia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Ambegia more than expected).

Fields of papers citing papers by Ellen Ambegia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Ambegia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Ambegia. The network helps show where Ellen Ambegia may publish in the future.

Co-authorship network of co-authors of Ellen Ambegia

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Ambegia. A scholar is included among the top collaborators of Ellen Ambegia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Ambegia. Ellen Ambegia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Semple, Sean C., Adam D. Judge, Marjorie Robbins, et al.. (2011). Abstract 2829: Preclinical characterization of TKM-080301, a lipid nanoparticle formulation of a small interfering RNA directed against polo-like kinase 1. Cancer Research. 71(8_Supplement). 2829–2829. 17 indexed citations

2.

Judge, Adam D., Marjorie Robbins, Iran Tavakoli, et al.. (2009). Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. Journal of Clinical Investigation. 119(3). 661–673. 273 indexed citations

3.

Toudjarska, Iva, Adam D. Judge, Kevin McClintock, et al.. (2009). Abstract B204: Development of ALN-VSP: An RNAi therapeutic for liver malignancies. Molecular Cancer Therapeutics. 8(12_Supplement). B204–B204. 2 indexed citations

4.

Robbins, Marjorie, Adam D. Judge, Ellen Ambegia, et al.. (2008). Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation. Human Gene Therapy. 19(10). 991–999. 172 indexed citations

5.

Robbins, Marjorie, Adam D. Judge, Ellen Ambegia, et al.. (2008). Misinterpreting the therapeutic effects of siRNA caused by immune stimulation. Human Gene Therapy. 0(ja). 3420089880–3420089880. 33 indexed citations

6.

Ambegia, Ellen, Steven M. Ansell, P.R. Cullis, et al.. (2005). Stabilized plasmid–lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1669(2). 155–163. 171 indexed citations

7.

Jeffs, Lloyd B., et al.. (2005). A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA. Pharmaceutical Research. 22(3). 362–372. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact